Evidence map›Paper›PMID 31925567›Full record

ArticleBasic research in cardiology2020

TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation.

Ravi K Adapala, Anantha K Kanugula, Sailaja Paruchuri, William M Chilian, Charles K Thodeti

Open access · greenAbstract read
In one paragraph

Article in Basic research in cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. TRPV4-Mediated Mechanosensing Regulates the Endothelial-to-Mesenchymal Transition: Implications for Atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Mechanosensitive ion channels and inflammation: key links in cellular signal transduction.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  12. Article
  13. CaBiomedicines · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ravi K AdapalaDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, 44272, USA.
Anantha K KanugulaDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, 44272, USA.
Sailaja ParuchuriDepartment of Chemistry, University of Akron, Akron, OH, 44325, USA.
William M ChilianDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, 44272, USA.
Charles K ThodetiDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, 44272, USA. cthodeti@neomed.edu.
Northeast Ohio Medical University · USKent State University · USUniversity of Akron · US

Funding

Mechanical Control of Coronary Angiogenesis in Myocardial Adaptation to IschemiaR01HL148585 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI THODETI, CHARLES K · 2019 to 2022
$1.8M
Integration of Leukotriene and Prostaglandin Receptor Signaling in Mast Cell Activation and Pulmonary Inflammation during AsthmaR01AI144115 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI PARUCHURI, SAILAJA · 2019 to 2023
$1.8M
Mechanotransduction in myocardial adaptation to ischemiaR01HL119705 · NHLBI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI THODETI, CHARLES K · 2015 to 2018
$1.5M
Integration of Mechanical and Soluble Signaling in Tumor AngiogenesisR15CA202847 · NCI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI THODETI, CHARLES K · 2016 to 2016
$453k
NCI NIH HHS R15 CA202847NHLBI NIH HHS R01 HL119705NHLBI NIH HHS R01 HL148585NIAID NIH HHS R01 AI144115
6 · The paper itself

Abstract

Cardiac fibrosis caused by adverse cardiac remodeling following myocardial infarction can eventually lead to heart failure. Although the role of soluble factors such as TGF-β is well studied in cardiac fibrosis following myocardial injury, the physiological role of mechanotransduction is not fully understood. Here, we investigated the molecular mechanism and functional role of TRPV4 mechanotransduction in cardiac fibrosis. TRPV4KO mice, 8 weeks following myocardial infarction (MI), exhibited preserved cardiac function compared to WT mice. Histological analysis demonstrated reduced cardiac fibrosis in TRPV4KO mice. We found that WT CF exhibited hypotonicity-induced calcium influx and extracellular matrix (ECM)-stiffness-dependent differentiation in response to TGF-β1. In contrast, TRPV4KO CF did not display hypotonicity-induced calcium influx and failed to differentiate on high-stiffness ECM gels even in the presence of saturating amounts of TGF-β1. Mechanistically, TRPV4 mediated cardiac fibrotic gene promoter activity and fibroblast differentiation through the activation of the Rho/Rho kinase pathway and the mechanosensitive transcription factor MRTF-A. Our findings suggest that genetic deletion of TRPV4 channels protects heart from adverse cardiac remodeling following MI by modulating Rho/MRTF-A pathway-mediated cardiac fibroblast differentiation and cardiac fibrosis.

Indexed as

Cell DifferentiationGene DeletionVentricular RemodelingAnimalsCalcium SignalingCells, CulturedDisease Models, AnimalExtracellular MatrixFibroblastsFibrosisMechanotransduction, CellularMice, Inbred C57BLMice, KnockoutMyocardial InfarctionMyocardiumrho-Associated KinasesMrtfa protein, mouserho-Associated Kinasesrho GTP-Binding ProteinsTrans-ActivatorsTrpv4 protein, mouseTRPV Cation ChannelsCardiac fibroblastCardiac fibrosisMechanotransductionMyocardial infarctionRho/Rho kinaseTGF-β1TRPV4

Identifiers

PMID31925567
PMCPMC7322630
OpenAlexW2999744331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.